Access site complications following transfemoral coronary procedures: comparison between traditional compression and angioseal vascular closure devices for haemostasis

Table 1 Demographic and clinical characteristics of the study sample

Variable	Total number (n = 130)		Traditional compression (n = 65)		Angioseal (n = 65)		Statistics	p
	n	%	n	%	n	%
Gender							χ² = 3.43	.06
Male	99	76.2	45	69.2	54	83.1
Female	31	23.8	20	30.8	11	16.9
Age M ± SD	64.2 ± 9.7		64.9 ± 9.3		63.4 ± 10.2		t = .86	.39
(range)	(32-80)		(42-79)		(32-80)
BMI M ± SD	25.6 ± 3.5		25.5 ± 3.8		25.8 ± 3.2		t = -.56	.58
(range)	(17.3-34.4)		(17.6-34.0)		(17.3-34.4)
Comorbidity
Hypertension	92	70.8	48	73.9	44	67.7	χ² = .34	.56
Hyperlipidemia	44	33.8	21	32.3	23	35.4	χ² = .03	.85
Diabetic Mellitus	32	24.6	20	30.8	12	18.5	χ² = 2.03	.15
Renal Disease	4	3.1	3	4.6	1	1.5		^#.62
COPD	1	0.8	0	0.0	1	1.5		^#.00
Total number of comorbidity M ± SD	1.3 ± 0.9		1.4 ± 0.9		1.3 ± 0.9		t = .37	.29
(range)	(0-4)		(0-4)		(0-3)
Type of catheterization							χ² = .56	.46
Diagnostic	43	33.1	19	29.2	24	36.9
Interventional	87	66.9	46	70.8	41	63.1
Time spent for catheterization (minutes) M ± SD	82.2 ± 42.1		82.2 ± 44.8		82.1 ± 39.5		t = .01	.99
(range)	(15-252)		(15-220)		(25-252)
Dose of anticoagulant M ± SD	4153.9 ± 3003.8		4053.9 ± 3199.3		4253.9 ± 2816.1		t = -.38	.71
(range)	(0-12500)		(0-12000)		(0-12500)
Number of stent placement							χ² = 3.74	.15
0	58	44.6	34	52.3	24	36.9
1	45	34.6	21	32.3	24	36.9
2 and above	27	20.8	10	15.4	17	26.2

M Mean, SD Standard deviation, COPD Chronic Obstructive Pulmonary Disease, χ² Chi-Square Tests, t independent t-test
^#: Fisher’s Exact test

ISSN: 1471-2261